8-K: Alignment Healthcare Beats Guidance, Projects Strong 2026 Growth

Alignment Healthcare, Inc. reported strong fourth quarter and full-year 2025 financial results, exceeding guidance across all key metrics and raising 2026 membership and revenue outlook.

Summary

• Full-year 2025 total revenue reached $3.95 billion, representing 46.1% growth year-over-year.
• The company exceeded the high-end of its fourth quarter and full-year guidance across all key metrics: membership, revenue, adjusted gross profit, and adjusted EBITDA.
• Health plan membership at the end of Q4 2025 was approximately 236,300, an increase of 25.0% year-over-year.
• Q4 2025 total revenue was $1,012.8 million, up 44.4% year-over-year.
• Q4 2025 adjusted gross profit was $124.9 million and adjusted EBITDA was $11.4 million.
• Full-year 2025 adjusted gross profit was $494.8 million and adjusted EBITDA was $109.9 million.
• The company achieved free cash flow on a full-year basis for 2025.
• Health plan membership guidance for 2026 has been raised by 2,000 at the midpoint, with an expected range of 292,000 to 298,000 members.
• Introduced 2026 revenue guidance of $5.14 billion to $5.19 billion, representing 30%-31% growth year-over-year.
• Introduced 2026 adjusted EBITDA guidance of $133 million to $163 million.
• Alignment Healthcare earned recognition on the 2026 Fortune World's Most Admired Companies list.

Sentiment

Score: 8

Explanation: StockSavvy.ai views this as a very positive report, driven by strong financial performance exceeding guidance, robust growth projections for 2026, and a clear path towards sustained profitability and free cash flow.

Positives

• Exceeded high-end of fourth quarter and full-year 2025 guidance across all key metrics (membership, revenue, adjusted gross profit, adjusted EBITDA).
• Full-year 2025 total revenue grew significantly by 46.1% year-over-year to $3.95 billion.
• Q4 2025 total revenue increased by 44.4% year-over-year to $1,012.8 million.
• Health plan membership grew 25.0% year-over-year to approximately 236,300 members.
• Achieved a positive step forward in profitability and margin expansion, including producing free cash flow on a full-year basis.
• Raised 2026 health plan membership guidance by 2,000 at the midpoint, projecting 292,000 to 298,000 members.
• Introduced strong 2026 revenue guidance of $5.14 billion to $5.19 billion, indicating 30%-31% year-over-year growth.
• Introduced 2026 adjusted EBITDA guidance of $133 million to $163 million, signaling continued profitability growth.
• Earned recognition on the 2026 Fortune World's Most Admired Companies list, affirming its reputation and innovative approach to senior healthcare.

Negatives

• Reported a net loss attributable to Alignment Healthcare, Inc. of $11.0 million for Q4 2025.
• Reported a net loss attributable to Alignment Healthcare, Inc. of $0.724 million for full-year 2025.
• Loss from operations was $10.3 million for Q4 2025.

Risks

• Ability to attract new members and enter new markets, including the need for certain governmental approvals.
• Ability to maintain a high rating for plans on the Five Star Quality Rating System.
• Ability to develop and maintain satisfactory relationships with care providers that service members.
• Risks associated with being a government contractor, including potential federal reductions in Medicare Advantage (MA) funding.
• Changes in laws and regulations applicable to the business model.
• Risks related to indebtedness.
• Changes in market or industry conditions and receptivity to technology and services.
• Results of litigation or a security incident.
• Impact of shortages of qualified personnel and related increases in labor costs.

Future Outlook

Alignment Healthcare projects strong growth for 2026, with revenue expected to be between $5.14 billion and $5.19 billion, representing 30%-31% year-over-year growth. Adjusted EBITDA is forecasted to be between $133 million and $163 million, and health plan membership guidance has been raised by 2,000 at the midpoint to a range of 292,000 to 298,000 members.

Management Comments

• "Our fourth quarter and full-year 2025 results show what Medicare Advantage done right looks like," said John Kao, founder and CEO.
• "We once again exceeded industry expectations and delivered continued momentum on revenue growth while taking a positive step forward in profitability and margin expansion, including producing free cash flow on a full-year basis."
• "By leading with our care model, we are putting our seniors first and lowering costs by delivering more care, not less."
• "Being named to the 2026 Fortune World's Most Admired Companies list affirms the reputation weve built since going public."
• "As we move through 2026, we remain focused on disciplined growth, the scalability of our operations and creating long-term value for the members we serve."

Industry Context

StockSavvy.ai notes that Alignment Healthcare's strong membership and revenue growth, coupled with improved profitability and free cash flow generation, positions it favorably within the competitive Medicare Advantage market. The company's focus on a differentiated care model and its recognition on the Fortune World's Most Admired Companies list suggest a strong brand and operational execution in a sector increasingly scrutinized for value and quality of care.

Comparison to Industry Standards

• The company's 46.1% year-over-year revenue growth for full-year 2025 significantly outpaces the average growth rates of many established Medicare Advantage providers, indicating strong market penetration and member acquisition.
• Achieving free cash flow on a full-year basis is a notable milestone, demonstrating improved operational efficiency and financial health compared to earlier-stage growth companies in the healthcare sector.
• Recognition on the 2026 Fortune World's Most Admired Companies list places Alignment Healthcare among a select group of highly regarded global enterprises, reflecting strong corporate reputation and innovative practices in senior healthcare.

Stakeholder Impact

• Shareholders: Positive impact due to strong financial performance, exceeding guidance, increased membership, and positive future outlook, potentially leading to increased share value.
• Members: Positive impact through the company's care model focused on putting seniors first and lowering costs by delivering more care.
• Employees: Potential positive impact from a growing company recognized as a "World's Most Admired Company," though restructuring costs were mentioned in non-GAAP adjustments.
• Care Providers: Continued partnership and satisfactory relationships are crucial for the business model.

Next Steps

• Focus on disciplined growth in 2026.
• Focus on the scalability of operations in 2026.
• Continue creating long-term value for members.
• Host a conference call on February 26, 2026, at 5 p.m. EST to discuss results and management's outlook for future financial and operational performance.

Key Dates

Recommendation

The company significantly outperformed its own guidance across all key metrics for both the quarter and the full year, demonstrating strong operational execution and market demand. The upward revision of 2026 membership guidance and robust revenue and EBITDA projections signal continued strong growth and an accelerating path to profitability. Achieving full-year free cash flow is a critical positive indicator of financial health and sustainability. These factors, combined with industry recognition, suggest a compelling investment opportunity.

Keywords

Medicare Advantage, Healthcare, Managed Care, Financial Results, Earnings, Revenue Growth, EBITDA, Membership Growth, ALHC, Health Plan, Senior Care, Q4 2025, Full Year 2025, 2026 Guidance